Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Role of Matrix Metalloproteinases for the Outcome of Surgical Revascularization in Patients With Critical Limb Ischemia

NCT02388867 is registered in ClinicalTrials.gov with University of Catanzaro as lead sponsor.

NCT NCT02388867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02388867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Role of Matrix Metalloproteinases for the Outcome of Surgical Revascularization in Patients With Critical Limb Ischemia
Lead sponsor
University of Catanzaro
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
March 31, 2015
Enrollment
30 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia, extracellular matrix alteration, peripheral revascularisation